DLM 261 (user guide here):
DLM 260 introduced some changes to prescribing decision support, which have caused issues for some users. DLM 261 makes some changes to reduce their impact.
Prescribing in Vision has, since the earliest versions, included some checks of the proposed prescription to ensure that the item to be prescribed is safe for the patient in question. These checks take various forms and are done by the knowledge embedded in Vision by FDBE - Multilex, our drug knowledge partner. They include Contraindications, Precautions, Warnings, Drug-Drug Interactions and Drug Doubling checks.
There has been no change in the checks performed or the knowledge to support those checks with the introduction of DLM 260, but there have been changes in the way that information is presented.
DLM 262 (user guide here):
(262, essentially, does something similar to 261)
- Human papillomavirus (Cervarix) now included in Types of Immunisation
- Minimum period for drug check for interactions and drug doubling reduced from 30 to 7 days for non-Scottish practices.